Moderately Hypofractionated Intensity Modulated Radiation Therapy With Simultaneous Integrated Boost for Prostate Cancer: Five-Year Toxicity Results From a Prospective Phase I/II Trial is a research paper published in Frontiers in Oncology (2020). On theSindex it has a DataRank of 0.334. It has been cited 5 times, with 4 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.269
From this paper's citation signal
Citation Network Contribution
0.0655
From 1 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 4 citers.
NCI NIH HHS
Grant: P30 CA016059
National Institutes of Health
Grant: 4P30CA016059-35
Massey Cancer Center Support Grant
Center for Strategic Scientific Initiatives, National Cancer Institute
FWCI
0.44
Citation Percentile
0.7%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals